-- New York, October 23, 2018: Market Research Engine has published a new report titled as " Zika Virus Testing Market By Test Type (Molecular Test, Serologic Test, Plaque Reduction Neutralization Test (PRNT)); By End-User (Hospital/Clinic, Research/Diagnostics Laboratory) and by Regional Analysis - Global Forecast by 2018 – 2024.”
The scope of the report includes a detailed study of Zika Virus Testing Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Gen-Probe Inc., F. Hoffmann La Roche Ltd., DiagnoCure Inc., and Siemens Healthcare. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
Zika may be a flavivirus responsible to cause an illness transmitted by Ades mosquitoes. It can even be transferred from one person to a different by sexual contact or from the mother to the foetus throughout gestation. Symptoms of the illness embody headache, nausea, fatigue, fever, and rash.
Browse Full Report from here: https://www.marketresearchengine.com/zika-virus-testing-market
The Zika Virus Testing Market has been segmented as below:
The Zika Virus Testing Market is segmented on the lines of By Test Type, By End-User and By Regional Analysis.
By Test Type this market is segmented on the basis of Molecular Test, Serologic Test and Plaque Reduction Neutralization Test (PRNT). By End-User this market is segmented on the basis of Hospital/Clinic and Research/Diagnostics Laboratory. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
This report provides:
1) An overview of the global market for Zika Virus Testing Market and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Zika Virus Testing Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The major driving factors of Zika Virus Testing Market are as follows:
Increasing Prevalence of Zika viral infection
Government Initiatives to Develop Innovative Tests
Increasing R&D by Biopharmaceutical corporations
Technological Advancements in Medical medicine
The major restraining factors of Zika Virus Testing Market are as follows:
High prices of Testing Kits
Sluggish Adoption of latest Technologies within the rising Markets
Request Sample Report from here: https://www.marketresearchengine.com/zika-virus-testing-market
Table of Contents
Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Stakeholders
Research Methodology
Report Summary
Market Overview
Zika Virus Testing Market Analysis, By End-User
Zika Virus Testing Market Analysis, By End-User
Zika Virus Testing Market Analysis, By Region
Competitive Overview
Company Profiles
9.1 Altona Diagnostics GmbH.
9.2 Chembio Diagnostic Systems Inc.
9.3 Abbott.
9.4 Genekam.
9.5 Luminex Corporation.
9.6 Fast Track Diagnostics Ltd.
9.7 Primerdesign Ltd.
9.8 ELITechGroup.
9.9 F. Hoffmann-La Roche Ltd.
9.10 Quest Diagnostics.
Other Related Market Research Reports:
Vulvodynia Treatment Market to hit more than US$ 8,091 Million by 2024
Varicella Zoster Infection Treatment Market to Perceive Substantial Growth During 2024
Contact Info:
Name: John Bay
Email: Send Email
Organization: Market Research Engine
Website: https://www.marketresearchengine.com/
Release ID: 430034
Google
RSS